Literature DB >> 8322776

The nephrotic syndrome, lipids, and risk factors for cardiovascular disease.

J Radhakrishnan1, A S Appel, A Valeri, G B Appel.   

Abstract

The hyperlipidemia associated with the nephrotic syndrome is well characterized. There is, however, a paucity of data in humans on the risk factors for atherosclerotic heart disease and the role of hyperlipidemia on the risk of progression of renal disease in this population. In our study, we retrospectively evaluated a large uniform population of patients (mean creatinine, 1.78 mg/dL; mean 24-hour proteinuria, 7.1 g) with idiopathic nephrotic syndrome for the presence of risk factors for coronary artery disease. One hundred patients with either focal segmental glomerulosclerosis (n = 56) or membranous nephropathy (n = 44) were assessed for the following cardiovascular risk factors: male sex or postmenopausal female, hyperlipidemia, hypertension, smoking history, and left ventricular hypertrophy. Sixty-six percent of the patients were either male or postmenopausal females; 35% were smokers. Hypertension and left ventricular hypertrophy were present in 53% and 13% of patients, respectively. Eighty-seven percent, 53%, and 25% of patients had a total cholesterol of more than 200 mg/dL, more than 300 mg/dL, and more than 400 mg/dL, respectively. Low-density lipoprotein cholesterol was greater than 130 mg/dL and greater than 160 mg/dL in 77.2% and 64.9% of patients, respectively. Virtually all patients (99%) had at least one risk factor for cardiovascular disease; over two thirds (68%) had two risk factors and over one quarter (26%) had three risk factors. In comparing the group that progressed to renal failure with the groups that did not, the initial mean serum cholesterol was lower in the group that progressed (292 mg/dL v 388 mg/dL, P < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8322776     DOI: 10.1016/s0272-6386(12)70179-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  18 in total

1.  Statin therapy in nephrotic syndrome.

Authors:  N N Chan
Journal:  J R Soc Med       Date:  1999-03       Impact factor: 5.344

2.  Treatment of steroid-resistant membranous lupus nephritis with plasmapheresis and low-dose cyclosporine.

Authors:  Shuichiro Fujinaga; Yoshiyuki Ohtomo; Daisuke Umino; Hiroshi Mochizuki; Mayako Takemoto; Toshiaki Shimizu; Yuichiro Yamashiro; Kazunari Kaneko
Journal:  Pediatr Nephrol       Date:  2006-11-07       Impact factor: 3.714

3.  The Evolving Role of Rituximab in Adult Minimal Change Glomerulopathy.

Authors:  Landon C Brown; Meghan A Jobson; Fernanda Payan Schober; Emily H Chang; Ronald J Falk; Patrick H Nachman; William F Pendergraft
Journal:  Am J Nephrol       Date:  2017-03-18       Impact factor: 3.754

4.  Patients with primary membranous nephropathy are at high risk of cardiovascular events.

Authors:  Taewoo Lee; Vimal K Derebail; Abhijit V Kshirsagar; Yunro Chung; Jason P Fine; Shannon Mahoney; Caroline J Poulton; Sophia Lionaki; Susan L Hogan; Ronald J Falk; Daniel C Cattran; Michelle Hladunewich; Heather N Reich; Patrick H Nachman
Journal:  Kidney Int       Date:  2016-02-26       Impact factor: 10.612

5.  Adult-onset minimal change disease: the significance of histological chronic changes for clinical presentation and outcome.

Authors:  Gabriel Stefan; Ruxandra Busuioc; Simona Stancu; Madalina Hoinoiu; Adrian Zugravu; Nicoleta Petre; Gabriel Mircescu
Journal:  Clin Exp Nephrol       Date:  2020-10-22       Impact factor: 2.801

6.  Comparison between the Effect of Cow Ghee and Butter on Memory and Lipid Profile of Wistar Rats.

Authors:  Yogita Surendra Karandikar; Akshata Sanjay Bansude; Eesha Ajit Angadi
Journal:  J Clin Diagn Res       Date:  2016-09-01

7.  Clinical features and outcomes of IgA nephropathy with nephrotic syndrome.

Authors:  Jwa-Kyung Kim; Jeong Ho Kim; Sang Choel Lee; Ea Wha Kang; Tae Ik Chang; Sung Jin Moon; Soo Young Yoon; Tae-Hyun Yoo; Shin-Wook Kang; Kyu Hun Choi; Dae Suk Han; Jeong Hae Kie; Beom Jin Lim; Hyeon Joo Jeong; Seung Hyeok Han
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

8.  Expression profiling of hepatic genes associated with lipid metabolism in nephrotic rats.

Authors:  Yunfeng Zhou; Xiaoyan Zhang; Lihong Chen; Jing Wu; Huaixin Dang; Mingfen Wei; Yanbo Fan; Yahua Zhang; Yi Zhu; Nanping Wang; Matthew D Breyer; Youfei Guan
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-09

9.  Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome.

Authors:  Maria H Kniazewska; Anna K Obuchowicz; Tomasz Wielkoszyński; Joanna Zmudzińska-Kitczak; Katarzyna Urban; Marta Marek; Jolanta Witanowska; Karolina Sieroń-Stołtny
Journal:  Pediatr Nephrol       Date:  2008-10-30       Impact factor: 3.714

10.  Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with De Novo Minimal Change Disease: A Multicenter, Randomized, Controlled Trial.

Authors:  Nicholas Rhys Medjeral-Thomas; Christopher Lawrence; Marie Condon; Bhrigu Sood; Paul Warwicker; Heather Brown; James Pattison; Sunil Bhandari; Jonathan Barratt; Neil Turner; H Terence Cook; Jeremy B Levy; Liz Lightstone; Charles Pusey; Jack Galliford; Thomas D Cairns; Megan Griffith
Journal:  Clin J Am Soc Nephrol       Date:  2020-01-17       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.